VISA INC., 10-Q filed on 1/30/2026
Quarterly Report
v3.25.4
Cover - shares
3 Months Ended
Dec. 31, 2025
Jan. 22, 2026
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2025  
Document Transition Report false  
Entity File Number 001-33977  
Entity Registrant Name VISA INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 26-0267673  
Entity Address, Address Line One P.O. Box 8999  
Entity Address, City or Town San Francisco,  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94128-8999  
City Area Code 650  
Local Phone Number 432-3200  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001403161  
Current Fiscal Year End Date --09-30  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Class A Common Stock    
Document Information [Line Items]    
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share  
Trading Symbol V  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   1,681,093,942
2026 Notes    
Document Information [Line Items]    
Title of 12(b) Security 1.500% Senior Notes due 2026  
Trading Symbol V26  
Security Exchange Name NYSE  
2028 Notes    
Document Information [Line Items]    
Title of 12(b) Security 2.250% Senior Notes due 2028  
Trading Symbol V28  
Security Exchange Name NYSE  
2029 Notes    
Document Information [Line Items]    
Title of 12(b) Security 2.000% Senior Notes due 2029  
Trading Symbol V29  
Security Exchange Name NYSE  
2033 Notes    
Document Information [Line Items]    
Title of 12(b) Security 3.125% Senior Notes due 2033  
Trading Symbol V33  
Security Exchange Name NYSE  
2034 Notes    
Document Information [Line Items]    
Title of 12(b) Security 2.375% Senior Notes due 2034  
Trading Symbol V34  
Security Exchange Name NYSE  
2037 Notes    
Document Information [Line Items]    
Title of 12(b) Security 3.500% Senior Notes due 2037  
Trading Symbol V37  
Security Exchange Name NYSE  
2044 Notes    
Document Information [Line Items]    
Title of 12(b) Security 3.875% Senior Notes due 2044  
Trading Symbol V44  
Security Exchange Name NYSE  
Class B-1 common stock    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   4,835,384
Class B-2 common stock    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   120,338,948
Class C common stock    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   8,904,197
v3.25.4
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions
Dec. 31, 2025
Sep. 30, 2025
Assets    
Cash and cash equivalents $ 14,756 $ 17,164
Restricted cash equivalents—U.S. litigation escrow 3,300 2,990
Investment securities 1,641 1,833
Settlement receivable 3,212 4,191
Accounts receivable 3,231 3,126
Customer collateral 3,712 3,625
Current portion of client incentives 2,280 2,158
Prepaid expenses and other current assets 2,865 2,679
Total current assets 34,997 37,766
Investment securities 484 999
Client incentives 5,541 5,157
Property, equipment and technology, net 4,276 4,236
Goodwill 19,885 19,879
Intangible assets, net 27,664 27,646
Other assets 3,967 3,944
Total assets 96,814 99,627
Liabilities    
Accounts payable 433 555
Settlement payable 4,337 4,568
Customer collateral 3,712 3,625
Accrued compensation and benefits 1,158 1,863
Client incentives 11,280 10,369
Accrued liabilities 5,576 5,466
Current maturities of debt 1,589 5,569
Accrued litigation 3,406 3,033
Total current liabilities 31,491 35,048
Long-term debt 19,588 19,602
Deferred tax liabilities 5,241 5,549
Other liabilities 1,717 1,519
Total liabilities 58,037 61,718
Commitments and contingencies (Note 14)
Equity    
Preferred stock 551 745
Right to recover for covered losses (19) (124)
Additional paid-in capital 21,980 21,934
Accumulated income 16,018 15,106
Accumulated other comprehensive income (loss):    
Investment securities 10 12
Defined benefit pension and other postretirement plans (30) (32)
Derivative instruments (245) (307)
Foreign currency translation adjustments 512 575
Total accumulated other comprehensive income (loss) 247 248
Total equity 38,777 37,909 [1]
Total liabilities and equity 96,814 99,627
Class A common stock    
Liabilities    
Accrued liabilities 40  
Equity    
Common stock 0 0
Class B-1 and B-2 common stock    
Equity    
Common stock 0 0
Class C common stock    
Equity    
Common stock $ 0 $ 0
[1] As of December 31, 2025 and September 30, 2025, the book value of series A convertible participating preferred stock (series A preferred stock) was $428 million and $513 million, respectively. See Note 4—U.S. and Europe Retrospective Responsibility Plans for the book value of series B convertible participating preferred stock (series B preferred stock) and series C convertible participating preferred stock (series C preferred stock).
v3.25.4
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares
shares in Millions
Dec. 31, 2025
Sep. 30, 2025
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares issued (in shares) 5 5
Preferred stock, shares outstanding (in shares) 5 5
Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Class A common stock    
Common stock, shares issued (in shares) 1,683 1,691
Common stock, shares outstanding (in shares) 1,683 1,691
Class B-1 and B-2 common stock    
Common stock, shares issued (in shares) 125 125
Common stock, shares outstanding (in shares) 125 125
Class C common stock    
Common stock, shares issued (in shares) 9 9
Common stock, shares outstanding (in shares) 9 9
v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Net revenue $ 10,901 $ 9,510
Operating Expenses    
Personnel 1,764 1,813
Marketing 410 306
Network and processing 233 207
Professional fees 208 143
Depreciation and amortization 326 282
General and administrative 515 481
Litigation provision 708 44
Total operating expenses 4,164 3,276
Operating income 6,737 6,234
Non-operating Income (Expense)    
Interest expense (194) (182)
Investment income (expense) and other 183 148
Total non-operating income (expense) (11) (34)
Income before income taxes 6,726 6,200
Income tax provision 873 1,081
Net income $ 5,853 $ 5,119
Class A common stock    
Earnings Per Share    
Basic Earnings Per Share (in dollars per share) $ 3.03 $ 2.58
Basic Weighted-average Shares Outstanding (in shares) 1,687 1,729
Diluted Earnings Per Share (in dollars per share) $ 3.03 $ 2.58
Diluted Weighted-average Shares Outstanding (in shares) 1,933 1,985
Class B-1 common stock    
Earnings Per Share    
Basic Earnings Per Share (in dollars per share) $ 4.71 $ 4.04
Basic Weighted-average Shares Outstanding (in shares) 5 5
Diluted Earnings Per Share (in dollars per share) $ 4.71 $ 4.04
Diluted Weighted-average Shares Outstanding (in shares) 5 5
Class B-2 common stock    
Earnings Per Share    
Basic Earnings Per Share (in dollars per share) $ 4.61 $ 3.99
Basic Weighted-average Shares Outstanding (in shares) 120 120
Diluted Earnings Per Share (in dollars per share) $ 4.61 $ 3.98
Diluted Weighted-average Shares Outstanding (in shares) 120 120
Class C common stock    
Earnings Per Share    
Basic Earnings Per Share (in dollars per share) $ 12.13 $ 10.33
Basic Weighted-average Shares Outstanding (in shares) 9 10
Diluted Earnings Per Share (in dollars per share) $ 12.11 $ 10.32
Diluted Weighted-average Shares Outstanding (in shares) 9 10
v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Statement of Comprehensive Income [Abstract]    
Net income $ 5,853 $ 5,119
Investment securities:    
Net unrealized gain (loss) (2) (24)
Income tax effect 0 6
Defined benefit pension and other postretirement plans:    
Reclassification adjustments 3 1
Income tax effect (1) 0
Derivative instruments:    
Net unrealized gain (loss) 7 168
Income tax effect 4 (25)
Reclassification adjustments 64 (42)
Income tax effect (13) 7
Foreign currency translation adjustments:    
Translation adjustments 37 (935)
Income tax effect (100) (95)
Other comprehensive income (loss) (1) (939)
Comprehensive income $ 5,852 $ 4,180
v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)
shares in Millions, $ in Millions
Total
Preferred Stock
Common Stock and Additional Paid-in Capital
Right to Recover for Covered Losses
Accumulated Income
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Sep. 30, 2024   5        
Balance as of beginning of period at Sep. 30, 2024 $ 39,137 $ 1,031 [1] $ 21,229 $ (104) $ 17,289 $ (308)
Beginning balance (in shares) at Sep. 30, 2024     1,868      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 5,119       5,119  
Other comprehensive income (loss) (939)         (939)
VE territory covered losses (27)     (27)    
Recovery through conversion rate adjustments 0 $ (8)   8    
Conversions to class A common stock (in shares)   0 [2] 3      
Conversions to class A common stock 0 $ (119) $ 119      
Share-based compensation 224   $ 224      
Stock issued under equity plans (in shares)     3      
Stock issued under equity plans 127   $ 127      
Shares withheld for taxes related to stock issued under equity plans (in shares)     (1)      
Shares withheld for taxes related to stock issued under equity plans (235)   $ (235)      
Cash dividends declared and paid, at a quarterly amount per class A common stock (1,170)       (1,170)  
Repurchases of class A common stock (in shares)     (13)      
Repurchases of class A common stock (3,940)   $ (140)   (3,800)  
Ending balance (in shares) at Dec. 31, 2024   5        
Balance as of end of period at Dec. 31, 2024 $ 38,296 $ 904 [1] $ 21,324 (123) 17,438 (1,247)
Ending balance (in shares) at Dec. 31, 2024     1,860      
Beginning balance (in shares) at Sep. 30, 2025 5 5        
Balance as of beginning of period at Sep. 30, 2025 [3] $ 37,909 $ 745 $ 21,934 (124) 15,106 248
Beginning balance (in shares) at Sep. 30, 2025     1,825      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 5,853       5,853  
Other comprehensive income (loss) (1)         (1)
VE territory covered losses (3)     (3)    
Recovery through conversion rate adjustments (1) $ (109)   108    
Conversions to class A common stock (in shares)   0 [4] 1      
Conversions to class A common stock 0 $ (85) $ 85      
Share-based compensation 231   $ 231      
Stock issued under equity plans (in shares)     3      
Stock issued under equity plans 78   $ 78      
Shares withheld for taxes related to stock issued under equity plans (in shares)     (1)      
Shares withheld for taxes related to stock issued under equity plans (231)   $ (231)      
Cash dividends declared and paid, at a quarterly amount per class A common stock (1,293)       (1,293)  
Repurchases of class A common stock (in shares)     (11)      
Repurchases of class A common stock $ (3,765)   $ (117)   (3,648)  
Ending balance (in shares) at Dec. 31, 2025 5 5        
Balance as of end of period at Dec. 31, 2025 $ 38,777 $ 551 [3] $ 21,980 $ (19) $ 16,018 $ 247
Ending balance (in shares) at Dec. 31, 2025     1,817      
[1] As of December 31, 2024 and September 30, 2024, the book value of series A preferred stock was $421 million and $540 million, respectively. See Note 4—U.S. and Europe Retrospective Responsibility Plans for the book value of series B and series C preferred stock.
[2] Increase or decrease is less than one million.
[3] As of December 31, 2025 and September 30, 2025, the book value of series A convertible participating preferred stock (series A preferred stock) was $428 million and $513 million, respectively. See Note 4—U.S. and Europe Retrospective Responsibility Plans for the book value of series B convertible participating preferred stock (series B preferred stock) and series C convertible participating preferred stock (series C preferred stock).
[4] Increase or decrease is less than one million.
v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) (Parenthetical) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dividends declared, quarterly, per share (in dollars per share) $ 0.67 $ 0.59    
Dividends paid, quarterly, per share (in dollars per share) $ 0.67 $ 0.59    
Book value of preferred stock $ 551   $ 745  
Series A preferred stock        
Book value of preferred stock $ 428 $ 421 $ 513 $ 540
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating Activities    
Net income $ 5,853 $ 5,119
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Client incentives 4,269 3,797
Share-based compensation 231 224
Depreciation and amortization 326 282
Deferred income taxes (435) 38
VE territory covered losses (3) (27)
(Gains) losses on equity investments, net 7 75
Other 18 56
Change in operating assets and liabilities:    
Settlement receivable 981 657
Accounts receivable (109) (64)
Client incentives (3,808) (3,649)
Other assets 35 (10)
Accounts payable (114) (54)
Settlement payable (233) (673)
Accrued and other liabilities (611) (303)
Accrued litigation 373 (72)
Net cash provided by (used in) operating activities 6,780 5,396
Investing Activities    
Purchases of property, equipment and technology (378) (345)
Proceeds from maturities and sales of investment securities 725 2,042
Acquisitions, net of cash and restricted cash acquired 0 (906)
Purchases of other investments (5) (6)
Other investing activities 19 5
Net cash provided by (used in) investing activities 361 790
Financing Activities    
Repurchases of class A common stock (3,725) (4,011)
Repayments of debt (4,000) 0
Dividends paid (1,293) (1,170)
Proceeds from stock issued under equity plans 78 127
Taxes paid related to stock issued under equity plans (231) (235)
Other financing activities 185 (186)
Net cash provided by (used in) financing activities (8,986) (5,475)
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents 34 (508)
Increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents (1,811) 203
Cash, cash equivalents, restricted cash and restricted cash equivalents as of beginning of period 24,987 19,763
Cash, cash equivalents, restricted cash and restricted cash equivalents as of end of period 23,176 19,966
Supplemental Disclosure    
Cash paid for income taxes, net [1] 1,290 1,194
Interest payments on debt 213 213
Accruals related to purchases of property, equipment and technology $ 26 $ 40
[1] For the three months ended December 31, 2025 and 2024, the amount includes cash paid for federal transferable tax credits of $740 million and $1.1 billion, respectively.
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (Parenthetical) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Statement of Cash Flows [Abstract]    
Cash paid for transferable tax credits $ 740 $ 1,100
v3.25.4
Summary of Significant Accounting Policies
3 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 1—Summary of Significant Accounting Policies
Organization. Visa Inc., together with its subsidiaries (Visa or the Company), is a global payments technology company that facilitates secure, reliable and efficient global commerce and money movement. Visa provides transaction processing services (primarily authorization, clearing and settlement) among consumers, issuing and acquiring financial institutions and sellers through its electronic payments network, VisaNet. Visa is focused on extending, enhancing and investing in its proprietary advanced transaction processing network, VisaNet, to offer a single connection point for facilitating money movement to multiple endpoints through various form factors and innovative technologies across more than 200 countries and territories. Visa is not a financial institution and does not issue cards, extend credit or set rates and fees for account holders of Visa products. In most cases, account holder and seller relationships belong to, and are managed by, Visa’s financial institution clients.
Consolidation and basis of presentation. The accompanying unaudited consolidated financial statements include the accounts of Visa and its consolidated entities and are presented in accordance with accounting principles generally accepted in the United States of America (GAAP). The Company consolidates entities for which it has a controlling financial interest, as well as variable interest entities (VIEs) for which the Company is the primary beneficiary. The Company’s investments in VIEs have not been material to its unaudited consolidated financial statements as of and for the periods presented. Intercompany balances and transactions have been eliminated in consolidation.
The accompanying unaudited consolidated financial statements are presented in accordance with the U.S. Securities and Exchange Commission (SEC) requirements for Quarterly Reports on Form 10-Q and, consequently, do not include all of the annual disclosures required by GAAP. Reference should be made to Visa’s Annual Report on Form 10-K for the year ended September 30, 2025 for additional disclosures, including a summary of the Company’s significant accounting policies.
In the opinion of management, the accompanying unaudited consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods presented. The results of operations for interim periods are not necessarily indicative of results for the full year.
Use of estimates. The preparation of the accompanying unaudited consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenue and expenses during the reporting period. These estimates may change as new events occur and additional information is obtained, and will be recognized in the period in which such changes occur. Future actual results could differ materially from these estimates.
Recently adopted accounting pronouncement. In November 2025, the Financial Accounting Standards Board issued Accounting Standards Update 2025-09, which includes amendments to more closely align hedge accounting with the economics of an entity’s risk management activities. During the three months ended December 31, 2025, the Company early adopted this standard on a prospective basis. The adoption did not have a material impact on the unaudited consolidated financial statements.
v3.25.4
Revenue
3 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue
Note 2—Revenue
The nature, amount, timing and uncertainty of the Company’s revenue and cash flows and how they are affected by economic factors are most appropriately depicted through the Company’s revenue categories and geographical markets. The following tables disaggregate the Company’s net revenue by revenue category and by geography:
Three Months Ended
December 31,
20252024
(in millions)
Service revenue
$4,760 $4,208 
Data processing revenue
5,544 4,745 
International transaction revenue
3,652 3,442 
Other revenue
1,214 912 
Client incentives(4,269)(3,797)
Net revenue
$10,901 $9,510 

Three Months Ended
December 31,
20252024
(in millions)
U.S.$4,163 $3,738 
International6,738 5,772 
Net revenue
$10,901 $9,510 
For the three months ended December 31, 2025 and 2024, revenue from value-added services was $3.2 billion and $2.4 billion, respectively. Revenue from value-added services is recognized within data processing, other and service revenue.
As of December 31, 2025 and September 30, 2025, deferred revenue was $1.9 billion and $1.7 billion, respectively. Deferred revenue is recorded in accrued liabilities on the consolidated balance sheets.
Remaining performance obligations are comprised of deferred revenue and contract revenue that will be invoiced and recognized as revenue in future periods primarily related to value-added services. As of December 31, 2025, the remaining performance obligations were $5.4 billion. The Company expects approximately half to be recognized as revenue in the next two years and the remaining thereafter. However, the amount and timing of revenue recognition is affected by several factors, including contract modifications and terminations, which could impact the estimate of amounts allocated to remaining performance obligations and when such revenue could be recognized.
v3.25.4
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
3 Months Ended
Dec. 31, 2025
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Note 3—Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
The Company reconciles cash, cash equivalents, restricted cash and restricted cash equivalents reported on the consolidated balance sheets that aggregate to the beginning and ending balances shown in the consolidated statements of cash flows as follows:
December 31,
2025
September 30,
2025
(in millions)
Cash and cash equivalents$14,756 $17,164 
Restricted cash and restricted cash equivalents:
U.S. litigation escrow3,300 2,990 
Customer collateral3,712 3,625 
Prepaid expenses and other current assets 1,408 1,208 
Cash, cash equivalents, restricted cash and restricted cash equivalents
$23,176 $24,987 
v3.25.4
U.S. and Europe Retrospective Responsibility Plans
3 Months Ended
Dec. 31, 2025
Retrospective Responsibility Plans [Abstract]  
U.S. and Europe Retrospective Responsibility Plans
Note 4—U.S. and Europe Retrospective Responsibility Plans
U.S. Retrospective Responsibility Plan
Under the terms of the U.S. retrospective responsibility plan, the Company maintains an escrow account from which settlements of, or judgments in, certain litigation (U.S. covered litigation) are paid. The accrual related to the U.S. covered litigation could be either higher or lower than the U.S. litigation escrow account balance. See Note 14—Legal Matters.
The following table presents the changes in the U.S. litigation escrow account:
Three Months Ended
December 31,
20252024
 (in millions)
Balance as of beginning of period
$2,990 $3,089 
Deposits into the U.S. litigation escrow account500 — 
Payments to opt-out merchants(1), net of interest earned on escrow funds
(190)23 
Balance as of end of period
$3,300 $3,112 
(1)These payments are associated with the interchange multidistrict litigation. See Note 14—Legal Matters.
Europe Retrospective Responsibility Plan
Visa Inc., Visa International and Visa Europe are parties to certain existing and potential litigation relating to the setting of multilateral interchange fee rates in the Visa Europe territory (VE territory covered litigation). Under the terms of the Europe retrospective responsibility plan, the Company is entitled to recover certain losses resulting from VE territory covered litigation (VE territory covered losses) through periodic adjustments to the class A common stock conversion rates applicable to the series B and C preferred stock. VE territory covered losses are recorded in stockholders’ equity in the contra-equity account right to recover for covered losses before the corresponding adjustment to the applicable conversion rate is effected. Adjustments to the conversion rate may be executed once in any six-month period unless a single, individual loss greater than €20 million is incurred, in which case, the six-month limitation does not apply. When the adjustment to the conversion rate is made, the amount previously recorded in right to recover for covered losses is then recorded against the book value of the preferred stock within stockholders’ equity.
The following tables present the activities in the preferred stock and right to recover for covered losses within stockholders’ equity:
Three Months Ended
December 31, 2025
Preferred StockRight to Recover for Covered Losses
Series BSeries C
(in millions)
Balance as of beginning of period
$67 $165 $(124)
VE territory covered losses(1)
— — (3)
Recovery through conversion rate adjustments(2)
(60)(49)108 
Balance as of end of period
$7 $116 $(19)
Three Months Ended
December 31, 2024
Preferred StockRight to Recover for Covered Losses
Series BSeries C
(in millions)
Balance as of beginning of period
$104 $387 $(104)
VE territory covered losses(1)
— — (27)
Recovery through conversion rate adjustments
(5)(3)
Balance as of end of period
$99 $384 $(123)
(1)VE territory covered losses reflect litigation provision for settlements with merchants and additional legal costs. See Note 14—Legal Matters.
(2)Adjustments to right to recover for covered losses for the conversion rate adjustments differ from the actual recovered amounts due to differences in foreign exchange rates between the time the losses were incurred and the subsequent recovery through the conversion rate adjustments.
The following table presents the as-converted value of the preferred stock available to recover VE territory covered losses compared to the book value of preferred stock recorded within the Company’s consolidated balance sheets:
December 31, 2025September 30, 2025
As-converted
Value(1),(2)
Book
Value
As-converted
Value(1),(3)
Book
Value
(in millions)
Series B preferred stock$518 $7 $566 $67 
Series C preferred stock794 116 823 165 
Total1,312 123 1,389 232 
Less: right to recover for covered losses(19)(19)(124)(124)
Total recovery for covered losses available$1,293 $104 $1,265 $108 
(1)Figures in the table may not recalculate exactly due to rounding. As-converted value is based on unrounded numbers.
(2)As of December 31, 2025, the as-converted value of preferred stock is calculated as the product of: (a) 2 million and 3 million shares of the series B and C preferred stock outstanding, respectively; (b) 0.5960 and 0.7170, the class A common stock conversion rate applicable to the series B and C preferred stock outstanding, respectively; and (c) $350.71, Visa’s class A common stock closing stock price.
(3)As of September 30, 2025, the as-converted value of preferred stock is calculated as the product of: (a) 2 million and 3 million shares of the series B and C preferred stock outstanding, respectively; (b) 0.6690 and 0.7640, the class A common stock conversion rate applicable to the series B and C preferred stock outstanding, respectively; and (c) $341.38, Visa’s class A common stock closing stock price.
v3.25.4
Fair Value Measurements and Investments
3 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Investments
Note 5—Fair Value Measurements and Investments
Assets and Liabilities Measured at Fair Value on a Recurring Basis
 Fair Value Measurements
Using Inputs Considered as
 Level 1Level 2
 December 31,
2025
September 30,
2025
December 31,
2025
September 30,
2025
 (in millions)
Assets
Cash equivalents and restricted cash equivalents:
Money market funds
$12,272 $13,760 $ $— 
Investment securities:
Marketable equity securities
428 411  — 
U.S. government-sponsored debt securities
 — 180 305 
U.S. Treasury securities
1,517 2,116  — 
Other current and non-current assets:
Money market funds
25 28  — 
Derivative instruments
 — 83 62 
Total $14,242 $16,315 $263 $367 
Liabilities
Accrued compensation and benefits:
Deferred compensation liability
$300 $268 $ $— 
Accrued and other liabilities:
Derivative instruments
 — 230 319 
Total $300 $268 $230 $319 
Level 1 assets and liabilities. Money market funds, U.S. Treasury securities and marketable equity securities are classified as Level 1 within the fair value hierarchy, as fair value is based on unadjusted quoted prices in active markets for identical assets. The Company’s deferred compensation liability is measured at fair value based on marketable equity securities held under the deferred compensation plan.
Level 2 assets and liabilities. The fair value of U.S. government-sponsored debt securities, as provided by third-party pricing vendors, is based on quoted prices in active markets for similar, not identical, assets. Derivative instruments are valued using inputs that are observable in the market or can be derived principally from or corroborated by observable market data.
U.S. Government-sponsored Debt Securities and U.S. Treasury Securities
The amortized cost, gross unrealized gains and losses and fair value of debt securities were as follows:
December 31, 2025
Amortized
Cost
Gross UnrealizedFair
Value
GainsLosses
(in millions)
U.S. government-sponsored debt securities$179 $$— $180 
U.S. Treasury securities1,504 13 — 1,517 
Total$1,683 $14 $ $1,697 
September 30, 2025
Amortized
Cost
Gross UnrealizedFair
Value
GainsLosses
(in millions)
U.S. government-sponsored debt securities$304 $$— $305 
U.S. Treasury securities2,101 15 — 2,116 
Total$2,405 $16 $— $2,421 
The stated maturities of debt securities were as follows:
December 31,
2025
 (in millions)
Due within one year$1,341 
Due after one year through five years
356 
Total$1,697 
Equity Securities
Fair value measurement alternative. The Company’s investments in privately held companies do not have readily determinable fair values. These investments are measured at fair value on a non-recurring basis and are classified as Level 3 due to the absence of quoted market prices, the inherent lack of liquidity and the fact that significant inputs used to measure fair value are unobservable and require management’s judgment.
The following table summarizes the Company’s non-marketable equity securities held as of period end that were accounted for using the fair value measurement alternative:
December 31,
2025
September 30,
2025
(in millions)
Initial cost basis
$714 $711 
Adjustments:
Upward adjustments
567 564 
Downward adjustments, including impairment
(219)(219)
Carrying amount
$1,062 $1,056 
Unrealized gains and losses of the Company’s non-marketable equity securities held as of period end that were accounted for using the fair value measurement alternative were as follows:
Three Months Ended
December 31,
20252024
(in millions)
Upward adjustments$3 $— 
Downward adjustments, including impairment
$ $(91)
Other Fair Value Disclosures
Debt. Debt instruments are measured at amortized cost on the Company’s consolidated balance sheets. The fair value of the debt instruments, as provided by third-party pricing vendors, is based on quoted prices in active markets for similar, not identical, instruments. If measured at fair value in the financial statements, these instruments would be classified as Level 2 in the fair value hierarchy. As of December 31, 2025, the carrying value
and estimated fair value of debt was $21.2 billion and $19.4 billion, respectively. As of September 30, 2025, the carrying value and estimated fair value of debt was $25.2 billion and $23.3 billion, respectively.
Other financial instruments not measured at fair value. As of December 31, 2025, the carrying values of settlement receivable and payable, accounts receivable and payable, and customer collateral are an approximate fair value due to their generally short maturities. If measured at fair value in the financial statements, these instruments would be classified as Level 2 in the fair value hierarchy.
Non-financial assets. Certain non-financial assets such as goodwill, intangible assets and property, equipment and technology are subject to non-recurring fair value measurements if they are deemed to be impaired. The Company performed an annual impairment review of its indefinite-lived intangible assets and goodwill as of February 1, 2025, and concluded there was no impairment as of that date. No recent events or changes in circumstances indicated that impairment existed as of December 31, 2025.
v3.25.4
Leases
3 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Leases
Note 6—Leases
As of December 31, 2025, the Company had additional leases that had not yet commenced with estimated future payments of $560 million. These leases are expected to commence between fiscal 2027 and 2029 with lease terms between 9 and 14 years.
v3.25.4
Debt
3 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Debt
Note 7—Debt
The Company had outstanding debt as follows:
December 31,
2025
September 30,
2025
Effective Interest Rate(1)
(in millions, except percentages)
U.S. dollar notes
3.15% Senior Notes due December 2025
$ $4,000 3.26%
1.90% Senior Notes due April 2027
1,500 1,500 2.02%
0.75% Senior Notes due August 2027
500 500 0.84%
2.75% Senior Notes due September 2027
750 750 2.91%
2.05% Senior Notes due April 2030
1,500 1,500 2.13%
1.10% Senior Notes due February 2031
1,000 1,000 1.20%
4.15% Senior Notes due December 2035
1,500 1,500 4.23%
2.70% Senior Notes due April 2040
1,000 1,000 2.80%
4.30% Senior Notes due December 2045
3,500 3,500 4.37%
3.65% Senior Notes due September 2047
750 750 3.73%
2.00% Senior Notes due August 2050
1,750 1,750 2.09%
Euro notes
1.50% Senior Notes due June 2026
1,591 1,587 1.71%
2.25% Senior Notes due May 2028
1,473 1,470 2.57%
2.00% Senior Notes due June 2029
1,178 1,176 2.13%
3.125% Senior Notes due May 2033
1,178 1,176 3.20%
2.375% Senior Notes due June 2034
766 764 2.53%
3.50% Senior Notes due May 2037
766 764 3.62%
3.875% Senior Notes due May 2044
707 705 4.02%
Total debt
21,409 25,392 
Unamortized discounts and debt issuance costs(158)(171)
Hedge accounting fair value adjustments(2)
(74)(50)
Total carrying value of debt
$21,177 $25,171 
Reported as:
Current maturities of debt$1,589 $5,569 
Long-term debt19,588 19,602 
Total carrying value of debt
$21,177 $25,171 
(1)Effective interest rates disclosed do not reflect hedge accounting adjustments.
(2)Represents the fair value of interest rate swap agreements entered into on a portion of the outstanding senior notes.
Senior Notes
During the three months ended December 31, 2025, the Company repaid $4.0 billion of principal upon maturity of its senior notes due December 2025.
v3.25.4
Settlement Guarantee Management
3 Months Ended
Dec. 31, 2025
Settlement Guarantee Management [Abstract]  
Settlement Guarantee Management
Note 8—Settlement Guarantee Management
The Company indemnifies its financial institution clients for settlement losses suffered due to failure of any other client to fund its settlement obligations in accordance with the Visa operating rules. This indemnification creates settlement risk for the Company due to the difference in timing between the date of a payment transaction and the date of subsequent settlement. The Company maintains and regularly reviews global settlement risk
policies and procedures to manage settlement risk, which may require clients to post collateral if certain credit standards are not met. Historically, the Company has experienced minimal losses as a result of its settlement risk guarantee. However, the Company’s future obligations, which could be material under its guarantees, are not determinable as they are dependent upon future events.
The Company’s settlement exposure is limited to the amount of unsettled Visa payment transactions at any point in time, which vary significantly day to day. For the three months ended December 31, 2025, the Company’s maximum daily settlement exposure was $168.6 billion and the average daily settlement exposure was $98.4 billion. To mitigate the risk of settlement exposure, the Company has various forms of collateral including restricted cash, letters of credit, guarantees, pledged securities and beneficial rights to trust assets. As of December 31, 2025 and September 30, 2025, the Company had total collateral of $8.8 billion for both periods.
v3.25.4
Segment Information
3 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Segment Information
Note 9—Segment Information
The Company’s activities are interrelated, and each activity is dependent upon and supportive of the other. All significant operating decisions are based on analysis of Visa as a single global business. The Company has one reportable segment, Payment Services.
The Company’s chief operating decision maker (CODM) is the Chief Executive Officer, who uses consolidated net income in assessing performance and allocating resources. This profitability measure is used in the annual budgeting process, and to monitor current-period performance against budget and prior-period results in order to make key operating decisions. The CODM does not evaluate segment performance using asset information.
Significant expenses that are regularly provided to the CODM for the Company’s one reportable segment are presented on the consolidated statements of operations and are included within the reported measure of consolidated net income.
v3.25.4
Stockholders' Equity
3 Months Ended
Dec. 31, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
Note 10—Stockholders’ Equity
As-converted class A common stock. The number of shares outstanding and the number of shares of class A common stock on an as-converted basis were as follows:
December 31, 2025September 30, 2025
Shares
Outstanding
Conversion Rate Into 
Class A
Common Stock
As-converted Class A
Common
Stock(1)
Shares
Outstanding
Conversion Rate Into
Class A
Common Stock
As-converted Class A
Common
Stock(1)
(in millions, except conversion rate)
Series A preferred stock 
(2)
100.0000 7 — 
(2)
100.0000 
Series B preferred stock2 0.5960 1 0.6690 
Series C preferred stock3 0.7170 2 0.7640 
Class A common stock1,683  1,683 1,691 — 1,691 
Class B-1 common stock
5 1.5491 
(3)
7 1.5549 
(3)
Class B-2 common stock
120 1.5108 
(3)
182 120 1.5223 
(3)
183 
Class C common stock9 4.0000 36 4.0000 36 
Total1,918 1,930 
(1)Figures in the table may not recalculate exactly due to rounding. As-converted class A common stock is calculated based on unrounded numbers.
(2)The number of shares outstanding was less than one million.
(3)The class B-1 and class B-2 to class A common stock conversion calculations for dividend payments are based on a conversion rate rounded to the tenth decimal. Conversion rates are presented on a rounded basis.
Reduction in as-converted shares. The following table presents the reduction in the number of as-converted class B-1 and B-2 common stock after deposits into the U.S. litigation escrow account under the U.S. retrospective responsibility plan:
Three Months Ended
December 31,
20252024
(in millions, except per share data)
Reduction in equivalent number of class A common stock1 — 
Effective price per share(1)
$354.46 $— 
Deposits into the U.S. litigation escrow account
$500 $— 
(1)Effective price per share for each adjustment is calculated using the volume-weighted average price of the Company’s class A common stock over a pricing period in accordance with the Company’s current certificate of incorporation.
The following table presents the reduction in the number of as-converted series B and C preferred stock after the Company recovered VE territory covered losses through conversion rate adjustments under the Europe retrospective responsibility plan:
Three Months Ended
December 31, 2025
Three Months Ended
December 31, 2024
Series BSeries CSeries BSeries C
(in millions, except per share data)
Reduction in equivalent number of class A common stock 
(1)
 
(1)
— 
(1)
— 
(1)
Effective price per share(2)
$330.96 $330.96 $312.39 $312.39 
Recovery through conversion rate adjustments
$60 $49 $$
(1)The reduction in equivalent number of class A common stock was less than one million shares.
(2)Effective price per share for each adjustment is calculated using the volume-weighted average price of the Company’s class A common stock over a pricing period in accordance with the Company’s current certificates of designations for its series B and C preferred stock.
Common stock repurchases. The following table presents share repurchases in the open market:
Three Months Ended
December 31,
20252024
(in millions, except per share data)
Shares repurchased in the open market(1)
11 13 
Average repurchase cost per share(2)
$342.13 $300.61 
Total cost(2)
$3,765 $3,940 
(1)Shares repurchased in the open market are retired and constitute authorized but unissued shares.
(2)Figures in the table may not recalculate exactly due to rounding. Average repurchase cost per share and total cost are calculated based on unrounded numbers and include applicable taxes. As of December 31, 2025 and 2024, shares repurchased in the open market include unsettled repurchases of $40 million and $70 million, respectively.
In April 2025, the Company’s board of directors authorized a $30.0 billion share repurchase program, providing multi-year flexibility. This authorization has no expiration date. As of December 31, 2025, the Company’s share repurchase program had remaining authorized funds of $21.1 billion. All share repurchase programs authorized prior to April 2025 have been completed.
Dividends. For the three months ended December 31, 2025 and 2024, the Company declared and paid dividends of $1.3 billion and $1.2 billion, respectively. On January 27, 2026, the Company’s board of directors declared a quarterly cash dividend of $0.67 per share of class A common stock (determined in the case of all other outstanding common and preferred stock on an as-converted basis), payable on March 2, 2026 to all holders of record as of February 10, 2026
v3.25.4
Earnings Per Share
3 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Earnings Per Share
Note 11—Earnings Per Share
The following tables present earnings per share:
Three Months Ended
December 31, 2025
 Basic Earnings Per ShareDiluted Earnings Per Share
Income
Allocation
(A)(1)
Weighted-
Average
Shares
Outstanding (B)
Earnings per
Share =
(A)/(B)(2)
Income
Allocation
(A)(1)
Weighted-
Average
Shares
Outstanding (B)
Earnings per
Share =
(A)/(B)(2)
(in millions, except per share data)
Class A common stock$5,117 1,687 $3.03 $5,853 
(3)
1,933 
(3)
$3.03 
Class B-1 common stock23 $4.71 $23 $4.71 
Class B-2 common stock555 120 $4.61 $554 120 $4.61 
Class C common stock108 $12.13 $108 $12.11 
Participating securities50 Not presentedNot presented$50 Not presentedNot presented
Net income$5,853 
Three Months Ended
December 31, 2024
 Basic Earnings Per ShareDiluted Earnings Per Share
Income
Allocation
(A)(1)
Weighted-
Average
Shares
Outstanding (B)
Earnings per
Share =
(A)/(B)(2)
Income
Allocation
(A)(1)
Weighted-
Average
Shares
Outstanding (B)
Earnings per
Share =
(A)/(B)(2)
(in millions, except per share data)
Class A common stock$4,466 1,729 $2.58 $5,119 
(3)
1,985 
(3)
$2.58 
Class B-1 common stock20 $4.04 $20 $4.04 
Class B-2 common stock480 120 $3.99 $479 120 $3.98 
Class C common stock98 10 $10.33 $98 10 $10.32 
Participating securities55 Not presentedNot presented$55 Not presentedNot presented
Net income$5,119 
(1)Income allocation is based on the weighted-average number of as-converted class A common stock outstanding as shown in the table below.
(2)Figures in the table may not recalculate exactly due to rounding. Basic and diluted earnings per share are calculated based on unrounded numbers.
(3)Diluted class A common stock earnings per share calculation includes the assumed conversion of any class B-1, B-2 and C common stock and participating securities on an as-converted basis as shown in the table below and the incremental common stock equivalents related to employee stock plans, as calculated under the treasury stock method. For the three months ended December 31, 2025 and 2024, the common stock equivalents were not material for each period.

The following table presents the weighted-average number of as-converted class A common stock outstanding:
Three Months Ended
December 31,
20252024
(in millions)
Class B-1 common stock8 
Class B-2 common stock
183 186 
Class C common stock36 38 
Participating securities17 21 
v3.25.4
Share-based Compensation
3 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Share-based Compensation
Note 12—Share-based Compensation
The following table presents the equity awards granted to employees and non-employee directors under the amended and restated 2007 Equity Incentive Compensation Plan (EIP) for the three months ended December 31, 2025:
GrantedWeighted-Average Grant Date Fair ValueWeighted-Average Exercise Price
Non-qualified stock options714,321 $76.23 $324.13 
Restricted stock units2,458,039 $324.82 
Performance shares(1)
381,324 $344.15 
(1)Represents the maximum number of performance shares which could be earned.
For the three months ended December 31, 2025 and 2024, the Company recorded share-based compensation cost related to the EIP of $221 million and $215 million, respectively.
v3.25.4
Income Taxes
3 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes
Note 13—Income Taxes
For the three months ended December 31, 2025 and 2024, the effective income tax rates were 13% and 17%, respectively. For the three months ended December 31, 2025, a $333 million deferred tax benefit was recognized due to a change in the U.S. taxation of certain foreign earnings.
For the three months ended December 31, 2025, the Company’s gross unrecognized tax benefits increased $13 million and the Company’s net unrecognized tax benefits increased $11 million. The change in unrecognized tax benefits is related to various tax positions across several jurisdictions.
For fiscal 2016 through 2018, the Internal Revenue Service completed its examination of the Company’s U.S. federal income tax returns. The Company is filing an appeal due to an unresolved issue related to certain income tax deductions.
The Company’s tax filings are subject to examination by U.S. federal, state and foreign taxing authorities. The timing and outcome of the final resolutions of the various ongoing income tax examinations and refund claims are uncertain.
v3.25.4
Legal Matters
3 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Legal Matters
Note 14—Legal Matters
The Company is a party to various legal and regulatory proceedings. Some of these proceedings involve complex claims that are subject to substantial uncertainties and unascertainable damages. For those proceedings where a loss is determined to be only reasonably possible or probable but not estimable, the Company has disclosed the nature of the claim. Additionally, unless otherwise disclosed below with respect to these proceedings, the Company cannot provide an estimate of the possible loss or range of loss. Although the Company believes that it has strong defenses for the litigation and regulatory proceedings described below, it could, in the future, incur judgments or fines or enter into settlements of claims that could have a material adverse effect on the Company’s financial position, results of operations or cash flows. From time to time, the Company may engage in settlement discussions or mediations with respect to one or more of its outstanding litigation matters, either on its own behalf or collectively with other parties.
The litigation accrual is an estimate and is based on management’s understanding of its litigation profile, the specifics of each case, advice of counsel to the extent appropriate and management’s best estimate of incurred loss as of the balance sheet date.
The following table summarizes the activity related to accrued litigation:
 Three Months Ended
December 31,
 20252024
 (in millions)
Balance as of beginning of period
$3,033 $1,727 
Provision for uncovered legal matters1 17 
Provision for covered legal matters707 34 
Payments for legal matters(335)(129)
Balance as of end of period
$3,406 $1,649 
Accrual Summary—U.S. Covered Litigation
Visa Inc., Visa U.S.A. and Visa International are parties to certain legal proceedings that are covered by the U.S. retrospective responsibility plan, which the Company refers to as the U.S. covered litigation. An accrual for the U.S. covered litigation and a charge to the litigation provision are recorded when a loss is deemed to be probable and reasonably estimable. In making this determination, the Company evaluates available information, including but not limited to actions taken by the Company’s litigation committee. The total accrual related to the U.S. covered litigation could be either higher or lower than the escrow account balance. See further discussion below under U.S. Covered Litigation and Note 4—U.S. and Europe Retrospective Responsibility Plans.
The following table summarizes the accrual activity related to U.S. covered litigation:
 Three Months Ended
December 31,
 20252024
 (in millions)
Balance as of beginning of period
$2,698 $1,537 
Provision for interchange multidistrict litigation707 27 
Payments for U.S. covered litigation(207)— 
Balance as of end of period
$3,198 $1,564 
For the three months ended December 31, 2025, the Company recorded an additional accrual of $707 million and deposited $500 million into the U.S. litigation escrow account to address claims associated with the interchange multidistrict litigation. The accrual balance is consistent with the Company’s best estimate of its share of a probable and reasonably estimable loss with respect to the U.S. covered litigation. While this estimate is consistent with the Company’s view of the current status of the litigation, the probable and reasonably estimable loss or range of such loss could materially vary based on developments in the litigation. The Company will continue to consider and reevaluate this estimate in light of the substantial uncertainties with respect to the litigation. The Company is unable to estimate a potential loss or range of loss, if any, at trial if negotiated resolutions cannot be reached.
Accrual Summary—VE Territory Covered Litigation
Visa Inc., Visa International and Visa Europe are parties to certain legal proceedings that are covered by the Europe retrospective responsibility plan. Unlike the U.S. retrospective responsibility plan, the Europe retrospective responsibility plan does not have an escrow account that is used to fund settlements or judgments. The Company is entitled to recover VE territory covered losses through periodic adjustments to the class A common stock conversion rates applicable to the series B and C preferred stock. An accrual for the VE territory covered losses and a reduction to stockholders’ equity will be recorded when the loss is deemed to be probable and reasonably estimable. See further discussion below under VE Territory Covered Litigation and Note 4—U.S. and Europe Retrospective Responsibility Plans.
The following table summarizes the accrual activity related to VE territory covered litigation:
 Three Months Ended
December 31,
 20252024
(in millions)
Balance as of beginning of period
$9 $72 
Provision for VE territory covered litigation 
Payments for VE territory covered litigation(4)(21)
Balance as of end of period
$5 $58 
U.S. Covered Litigation
Interchange Multidistrict Litigation (MDL) - Class Actions
On November 10, 2025, Visa and Mastercard entered into a superseding and amended settlement agreement to resolve the Injunctive Relief Class claims and the Injunctive Relief Class plaintiffs filed a motion for preliminary approval of the settlement.
Interchange Multidistrict Litigation (MDL) – Individual Merchant Actions
Visa has reached settlements with a number of merchants representing approximately 87% of the Visa-branded payment card sales volume of merchants who opted out of the Amended Settlement Agreement with the Damages Class plaintiffs.
VE Territory Covered Litigation
Visa filed a jurisdictional challenge in the Dutch class action on December 17, 2025.
Other Litigation
U.S. Securities Class Action
On December 10, 2025, the court granted Visa’s motion to dismiss the amended complaint with leave to amend, and denied the motion to strike as moot. On January 9, 2026, plaintiff filed a second amended complaint, and Visa filed a motion to dismiss on January 23, 2026.
Debit Surcharge Class Action
On December 12, 2025, the court granted Visa’s motion to dismiss the amended complaint without further leave to amend. Plaintiff appealed but subsequently dismissed its appeal.
U.S. ATM Access Fee Litigation
On December 18, 2025, plaintiffs in Burke filed a motion for preliminary approval of the class settlement with Visa and Mastercard.
MiCamp Solutions
On December 11, 2025, the court granted Visa’s motion to dismiss and dismissed plaintiffs’ case without further leave to amend.
German ATM Litigation
Several of Visa’s jurisdictional challenges are pending in the German Federal Court of Justice.
v3.25.4
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.4
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Organization
Organization. Visa Inc., together with its subsidiaries (Visa or the Company), is a global payments technology company that facilitates secure, reliable and efficient global commerce and money movement. Visa provides transaction processing services (primarily authorization, clearing and settlement) among consumers, issuing and acquiring financial institutions and sellers through its electronic payments network, VisaNet. Visa is focused on extending, enhancing and investing in its proprietary advanced transaction processing network, VisaNet, to offer a single connection point for facilitating money movement to multiple endpoints through various form factors and innovative technologies across more than 200 countries and territories. Visa is not a financial institution and does not issue cards, extend credit or set rates and fees for account holders of Visa products. In most cases, account holder and seller relationships belong to, and are managed by, Visa’s financial institution clients.
Consolidation and basis of presentation
Consolidation and basis of presentation. The accompanying unaudited consolidated financial statements include the accounts of Visa and its consolidated entities and are presented in accordance with accounting principles generally accepted in the United States of America (GAAP). The Company consolidates entities for which it has a controlling financial interest, as well as variable interest entities (VIEs) for which the Company is the primary beneficiary. The Company’s investments in VIEs have not been material to its unaudited consolidated financial statements as of and for the periods presented. Intercompany balances and transactions have been eliminated in consolidation.
The accompanying unaudited consolidated financial statements are presented in accordance with the U.S. Securities and Exchange Commission (SEC) requirements for Quarterly Reports on Form 10-Q and, consequently, do not include all of the annual disclosures required by GAAP. Reference should be made to Visa’s Annual Report on Form 10-K for the year ended September 30, 2025 for additional disclosures, including a summary of the Company’s significant accounting policies.
In the opinion of management, the accompanying unaudited consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods presented. The results of operations for interim periods are not necessarily indicative of results for the full year.
Use of estimates
Use of estimates. The preparation of the accompanying unaudited consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenue and expenses during the reporting period. These estimates may change as new events occur and additional information is obtained, and will be recognized in the period in which such changes occur. Future actual results could differ materially from these estimates.
Recently adopted accounting pronouncement
Recently adopted accounting pronouncement. In November 2025, the Financial Accounting Standards Board issued Accounting Standards Update 2025-09, which includes amendments to more closely align hedge accounting with the economics of an entity’s risk management activities. During the three months ended December 31, 2025, the Company early adopted this standard on a prospective basis. The adoption did not have a material impact on the unaudited consolidated financial statements.
v3.25.4
Revenue (Tables)
3 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue The following tables disaggregate the Company’s net revenue by revenue category and by geography:
Three Months Ended
December 31,
20252024
(in millions)
Service revenue
$4,760 $4,208 
Data processing revenue
5,544 4,745 
International transaction revenue
3,652 3,442 
Other revenue
1,214 912 
Client incentives(4,269)(3,797)
Net revenue
$10,901 $9,510 

Three Months Ended
December 31,
20252024
(in millions)
U.S.$4,163 $3,738 
International6,738 5,772 
Net revenue
$10,901 $9,510 
v3.25.4
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Tables)
3 Months Ended
Dec. 31, 2025
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]  
Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
The Company reconciles cash, cash equivalents, restricted cash and restricted cash equivalents reported on the consolidated balance sheets that aggregate to the beginning and ending balances shown in the consolidated statements of cash flows as follows:
December 31,
2025
September 30,
2025
(in millions)
Cash and cash equivalents$14,756 $17,164 
Restricted cash and restricted cash equivalents:
U.S. litigation escrow3,300 2,990 
Customer collateral3,712 3,625 
Prepaid expenses and other current assets 1,408 1,208 
Cash, cash equivalents, restricted cash and restricted cash equivalents
$23,176 $24,987 
v3.25.4
U.S. and Europe Retrospective Responsibility Plans (Tables)
3 Months Ended
Dec. 31, 2025
Retrospective Responsibility Plans [Abstract]  
Schedule of Changes in the U.S. litigation escrow account
The following table presents the changes in the U.S. litigation escrow account:
Three Months Ended
December 31,
20252024
 (in millions)
Balance as of beginning of period
$2,990 $3,089 
Deposits into the U.S. litigation escrow account500 — 
Payments to opt-out merchants(1), net of interest earned on escrow funds
(190)23 
Balance as of end of period
$3,300 $3,112 
(1)These payments are associated with the interchange multidistrict litigation. See Note 14—Legal Matters.
Schedule of Changes in Preferred Stock and Right to Recover for Covered Losses
The following tables present the activities in the preferred stock and right to recover for covered losses within stockholders’ equity:
Three Months Ended
December 31, 2025
Preferred StockRight to Recover for Covered Losses
Series BSeries C
(in millions)
Balance as of beginning of period
$67 $165 $(124)
VE territory covered losses(1)
— — (3)
Recovery through conversion rate adjustments(2)
(60)(49)108 
Balance as of end of period
$7 $116 $(19)
Three Months Ended
December 31, 2024
Preferred StockRight to Recover for Covered Losses
Series BSeries C
(in millions)
Balance as of beginning of period
$104 $387 $(104)
VE territory covered losses(1)
— — (27)
Recovery through conversion rate adjustments
(5)(3)
Balance as of end of period
$99 $384 $(123)
(1)VE territory covered losses reflect litigation provision for settlements with merchants and additional legal costs. See Note 14—Legal Matters.
(2)Adjustments to right to recover for covered losses for the conversion rate adjustments differ from the actual recovered amounts due to differences in foreign exchange rates between the time the losses were incurred and the subsequent recovery through the conversion rate adjustments.
Schedule of Preferred Stock As-Converted Value and Book Value
The following table presents the as-converted value of the preferred stock available to recover VE territory covered losses compared to the book value of preferred stock recorded within the Company’s consolidated balance sheets:
December 31, 2025September 30, 2025
As-converted
Value(1),(2)
Book
Value
As-converted
Value(1),(3)
Book
Value
(in millions)
Series B preferred stock$518 $7 $566 $67 
Series C preferred stock794 116 823 165 
Total1,312 123 1,389 232 
Less: right to recover for covered losses(19)(19)(124)(124)
Total recovery for covered losses available$1,293 $104 $1,265 $108 
(1)Figures in the table may not recalculate exactly due to rounding. As-converted value is based on unrounded numbers.
(2)As of December 31, 2025, the as-converted value of preferred stock is calculated as the product of: (a) 2 million and 3 million shares of the series B and C preferred stock outstanding, respectively; (b) 0.5960 and 0.7170, the class A common stock conversion rate applicable to the series B and C preferred stock outstanding, respectively; and (c) $350.71, Visa’s class A common stock closing stock price.
(3)As of September 30, 2025, the as-converted value of preferred stock is calculated as the product of: (a) 2 million and 3 million shares of the series B and C preferred stock outstanding, respectively; (b) 0.6690 and 0.7640, the class A common stock conversion rate applicable to the series B and C preferred stock outstanding, respectively; and (c) $341.38, Visa’s class A common stock closing stock price.
v3.25.4
Fair Value Measurements and Investments (Tables)
3 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
Assets and Liabilities Measured at Fair Value on a Recurring Basis
 Fair Value Measurements
Using Inputs Considered as
 Level 1Level 2
 December 31,
2025
September 30,
2025
December 31,
2025
September 30,
2025
 (in millions)
Assets
Cash equivalents and restricted cash equivalents:
Money market funds
$12,272 $13,760 $ $— 
Investment securities:
Marketable equity securities
428 411  — 
U.S. government-sponsored debt securities
 — 180 305 
U.S. Treasury securities
1,517 2,116  — 
Other current and non-current assets:
Money market funds
25 28  — 
Derivative instruments
 — 83 62 
Total $14,242 $16,315 $263 $367 
Liabilities
Accrued compensation and benefits:
Deferred compensation liability
$300 $268 $ $— 
Accrued and other liabilities:
Derivative instruments
 — 230 319 
Total $300 $268 $230 $319 
Schedule of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Debt Securities
The amortized cost, gross unrealized gains and losses and fair value of debt securities were as follows:
December 31, 2025
Amortized
Cost
Gross UnrealizedFair
Value
GainsLosses
(in millions)
U.S. government-sponsored debt securities$179 $$— $180 
U.S. Treasury securities1,504 13 — 1,517 
Total$1,683 $14 $ $1,697 
September 30, 2025
Amortized
Cost
Gross UnrealizedFair
Value
GainsLosses
(in millions)
U.S. government-sponsored debt securities$304 $$— $305 
U.S. Treasury securities2,101 15 — 2,116 
Total$2,405 $16 $— $2,421 
Schedule of Debt Securities Classified by Contractual Maturity Date
The stated maturities of debt securities were as follows:
December 31,
2025
 (in millions)
Due within one year$1,341 
Due after one year through five years
356 
Total$1,697 
Schedule of Non-Marketable Equity Securities
The following table summarizes the Company’s non-marketable equity securities held as of period end that were accounted for using the fair value measurement alternative:
December 31,
2025
September 30,
2025
(in millions)
Initial cost basis
$714 $711 
Adjustments:
Upward adjustments
567 564 
Downward adjustments, including impairment
(219)(219)
Carrying amount
$1,062 $1,056 
Unrealized gains and losses of the Company’s non-marketable equity securities held as of period end that were accounted for using the fair value measurement alternative were as follows:
Three Months Ended
December 31,
20252024
(in millions)
Upward adjustments$3 $— 
Downward adjustments, including impairment
$ $(91)
v3.25.4
Debt (Tables)
3 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Debt
The Company had outstanding debt as follows:
December 31,
2025
September 30,
2025
Effective Interest Rate(1)
(in millions, except percentages)
U.S. dollar notes
3.15% Senior Notes due December 2025
$ $4,000 3.26%
1.90% Senior Notes due April 2027
1,500 1,500 2.02%
0.75% Senior Notes due August 2027
500 500 0.84%
2.75% Senior Notes due September 2027
750 750 2.91%
2.05% Senior Notes due April 2030
1,500 1,500 2.13%
1.10% Senior Notes due February 2031
1,000 1,000 1.20%
4.15% Senior Notes due December 2035
1,500 1,500 4.23%
2.70% Senior Notes due April 2040
1,000 1,000 2.80%
4.30% Senior Notes due December 2045
3,500 3,500 4.37%
3.65% Senior Notes due September 2047
750 750 3.73%
2.00% Senior Notes due August 2050
1,750 1,750 2.09%
Euro notes
1.50% Senior Notes due June 2026
1,591 1,587 1.71%
2.25% Senior Notes due May 2028
1,473 1,470 2.57%
2.00% Senior Notes due June 2029
1,178 1,176 2.13%
3.125% Senior Notes due May 2033
1,178 1,176 3.20%
2.375% Senior Notes due June 2034
766 764 2.53%
3.50% Senior Notes due May 2037
766 764 3.62%
3.875% Senior Notes due May 2044
707 705 4.02%
Total debt
21,409 25,392 
Unamortized discounts and debt issuance costs(158)(171)
Hedge accounting fair value adjustments(2)
(74)(50)
Total carrying value of debt
$21,177 $25,171 
Reported as:
Current maturities of debt$1,589 $5,569 
Long-term debt19,588 19,602 
Total carrying value of debt
$21,177 $25,171 
(1)Effective interest rates disclosed do not reflect hedge accounting adjustments.
(2)Represents the fair value of interest rate swap agreements entered into on a portion of the outstanding senior notes.
v3.25.4
Stockholders' Equity (Tables)
3 Months Ended
Dec. 31, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Stock by Class
As-converted class A common stock. The number of shares outstanding and the number of shares of class A common stock on an as-converted basis were as follows:
December 31, 2025September 30, 2025
Shares
Outstanding
Conversion Rate Into 
Class A
Common Stock
As-converted Class A
Common
Stock(1)
Shares
Outstanding
Conversion Rate Into
Class A
Common Stock
As-converted Class A
Common
Stock(1)
(in millions, except conversion rate)
Series A preferred stock 
(2)
100.0000 7 — 
(2)
100.0000 
Series B preferred stock2 0.5960 1 0.6690 
Series C preferred stock3 0.7170 2 0.7640 
Class A common stock1,683  1,683 1,691 — 1,691 
Class B-1 common stock
5 1.5491 
(3)
7 1.5549 
(3)
Class B-2 common stock
120 1.5108 
(3)
182 120 1.5223 
(3)
183 
Class C common stock9 4.0000 36 4.0000 36 
Total1,918 1,930 
(1)Figures in the table may not recalculate exactly due to rounding. As-converted class A common stock is calculated based on unrounded numbers.
(2)The number of shares outstanding was less than one million.
(3)The class B-1 and class B-2 to class A common stock conversion calculations for dividend payments are based on a conversion rate rounded to the tenth decimal. Conversion rates are presented on a rounded basis.
Schedule of Effect of VE Territory Covered Losses Recovery on the Company Repurchasing its Common Stock
Reduction in as-converted shares. The following table presents the reduction in the number of as-converted class B-1 and B-2 common stock after deposits into the U.S. litigation escrow account under the U.S. retrospective responsibility plan:
Three Months Ended
December 31,
20252024
(in millions, except per share data)
Reduction in equivalent number of class A common stock1 — 
Effective price per share(1)
$354.46 $— 
Deposits into the U.S. litigation escrow account
$500 $— 
(1)Effective price per share for each adjustment is calculated using the volume-weighted average price of the Company’s class A common stock over a pricing period in accordance with the Company’s current certificate of incorporation.
The following table presents the reduction in the number of as-converted series B and C preferred stock after the Company recovered VE territory covered losses through conversion rate adjustments under the Europe retrospective responsibility plan:
Three Months Ended
December 31, 2025
Three Months Ended
December 31, 2024
Series BSeries CSeries BSeries C
(in millions, except per share data)
Reduction in equivalent number of class A common stock 
(1)
 
(1)
— 
(1)
— 
(1)
Effective price per share(2)
$330.96 $330.96 $312.39 $312.39 
Recovery through conversion rate adjustments
$60 $49 $$
(1)The reduction in equivalent number of class A common stock was less than one million shares.
(2)Effective price per share for each adjustment is calculated using the volume-weighted average price of the Company’s class A common stock over a pricing period in accordance with the Company’s current certificates of designations for its series B and C preferred stock.
Schedule of Share Repurchase Program Disclosure
Common stock repurchases. The following table presents share repurchases in the open market:
Three Months Ended
December 31,
20252024
(in millions, except per share data)
Shares repurchased in the open market(1)
11 13 
Average repurchase cost per share(2)
$342.13 $300.61 
Total cost(2)
$3,765 $3,940 
(1)Shares repurchased in the open market are retired and constitute authorized but unissued shares.
(2)Figures in the table may not recalculate exactly due to rounding. Average repurchase cost per share and total cost are calculated based on unrounded numbers and include applicable taxes. As of December 31, 2025 and 2024, shares repurchased in the open market include unsettled repurchases of $40 million and $70 million, respectively.
v3.25.4
Earnings Per Share (Tables)
3 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following tables present earnings per share:
Three Months Ended
December 31, 2025
 Basic Earnings Per ShareDiluted Earnings Per Share
Income
Allocation
(A)(1)
Weighted-
Average
Shares
Outstanding (B)
Earnings per
Share =
(A)/(B)(2)
Income
Allocation
(A)(1)
Weighted-
Average
Shares
Outstanding (B)
Earnings per
Share =
(A)/(B)(2)
(in millions, except per share data)
Class A common stock$5,117 1,687 $3.03 $5,853 
(3)
1,933 
(3)
$3.03 
Class B-1 common stock23 $4.71 $23 $4.71 
Class B-2 common stock555 120 $4.61 $554 120 $4.61 
Class C common stock108 $12.13 $108 $12.11 
Participating securities50 Not presentedNot presented$50 Not presentedNot presented
Net income$5,853 
Three Months Ended
December 31, 2024
 Basic Earnings Per ShareDiluted Earnings Per Share
Income
Allocation
(A)(1)
Weighted-
Average
Shares
Outstanding (B)
Earnings per
Share =
(A)/(B)(2)
Income
Allocation
(A)(1)
Weighted-
Average
Shares
Outstanding (B)
Earnings per
Share =
(A)/(B)(2)
(in millions, except per share data)
Class A common stock$4,466 1,729 $2.58 $5,119 
(3)
1,985 
(3)
$2.58 
Class B-1 common stock20 $4.04 $20 $4.04 
Class B-2 common stock480 120 $3.99 $479 120 $3.98 
Class C common stock98 10 $10.33 $98 10 $10.32 
Participating securities55 Not presentedNot presented$55 Not presentedNot presented
Net income$5,119 
(1)Income allocation is based on the weighted-average number of as-converted class A common stock outstanding as shown in the table below.
(2)Figures in the table may not recalculate exactly due to rounding. Basic and diluted earnings per share are calculated based on unrounded numbers.
(3)Diluted class A common stock earnings per share calculation includes the assumed conversion of any class B-1, B-2 and C common stock and participating securities on an as-converted basis as shown in the table below and the incremental common stock equivalents related to employee stock plans, as calculated under the treasury stock method. For the three months ended December 31, 2025 and 2024, the common stock equivalents were not material for each period.
Schedule of Weighted Average Number of Shares as Converted
The following table presents the weighted-average number of as-converted class A common stock outstanding:
Three Months Ended
December 31,
20252024
(in millions)
Class B-1 common stock8 
Class B-2 common stock
183 186 
Class C common stock36 38 
Participating securities17 21 
v3.25.4
Share-based Compensation (Tables)
3 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The following table presents the equity awards granted to employees and non-employee directors under the amended and restated 2007 Equity Incentive Compensation Plan (EIP) for the three months ended December 31, 2025:
GrantedWeighted-Average Grant Date Fair ValueWeighted-Average Exercise Price
Non-qualified stock options714,321 $76.23 $324.13 
Restricted stock units2,458,039 $324.82 
Performance shares(1)
381,324 $344.15 
(1)Represents the maximum number of performance shares which could be earned.
v3.25.4
Legal Matters (Tables)
3 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Loss Contingencies by Contingency
The following table summarizes the activity related to accrued litigation:
 Three Months Ended
December 31,
 20252024
 (in millions)
Balance as of beginning of period
$3,033 $1,727 
Provision for uncovered legal matters1 17 
Provision for covered legal matters707 34 
Payments for legal matters(335)(129)
Balance as of end of period
$3,406 $1,649 
The following table summarizes the accrual activity related to U.S. covered litigation:
 Three Months Ended
December 31,
 20252024
 (in millions)
Balance as of beginning of period
$2,698 $1,537 
Provision for interchange multidistrict litigation707 27 
Payments for U.S. covered litigation(207)— 
Balance as of end of period
$3,198 $1,564 
The following table summarizes the accrual activity related to VE territory covered litigation:
 Three Months Ended
December 31,
 20252024
(in millions)
Balance as of beginning of period
$9 $72 
Provision for VE territory covered litigation 
Payments for VE territory covered litigation(4)(21)
Balance as of end of period
$5 $58 
v3.25.4
Summary of Significant Accounting Policies (Details)
Dec. 31, 2025
country
Accounting Policies [Abstract]  
Number of countries in which Visa operates (more than) 200
v3.25.4
Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Disaggregation of Revenue [Line Items]    
Net revenue $ 10,901 $ 9,510
U.S.    
Disaggregation of Revenue [Line Items]    
Net revenue 4,163 3,738
International    
Disaggregation of Revenue [Line Items]    
Net revenue 6,738 5,772
Service revenue    
Disaggregation of Revenue [Line Items]    
Net revenue 4,760 4,208
Data processing revenue    
Disaggregation of Revenue [Line Items]    
Net revenue 5,544 4,745
International transaction revenue    
Disaggregation of Revenue [Line Items]    
Net revenue 3,652 3,442
Other revenue    
Disaggregation of Revenue [Line Items]    
Net revenue 1,214 912
Client incentives    
Disaggregation of Revenue [Line Items]    
Net revenue $ (4,269) $ (3,797)
v3.25.4
Revenue - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Sep. 30, 2025
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Net revenue $ 10,901 $ 9,510  
Deferred revenue 1,900   $ 1,700
Value-Added Services      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Net revenue 3,200 $ 2,400  
Revenue, remaining performance obligation, amount $ 5,400    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Revenue, remaining performance obligation (in percent) 50.00%    
Revenue, remaining performance obligation, expected timing of satisfaction, period (in years) 2 years    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Revenue, remaining performance obligation (in percent) 50.00%    
Revenue, remaining performance obligation, expected timing of satisfaction, period (in years)    
v3.25.4
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents - Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Sep. 30, 2025
Dec. 31, 2024
Sep. 30, 2024
Restricted Cash and Cash Equivalent Item [Line Items]        
Cash and cash equivalents $ 14,756 $ 17,164    
Cash, cash equivalents, restricted cash and restricted cash equivalents 23,176 24,987 $ 19,966 $ 19,763
U.S. litigation escrow        
Restricted Cash and Cash Equivalent Item [Line Items]        
Restricted cash and restricted cash equivalents: 3,300 2,990    
Customer collateral        
Restricted Cash and Cash Equivalent Item [Line Items]        
Restricted cash and restricted cash equivalents: 3,712 3,625    
Prepaid expenses and other current assets        
Restricted Cash and Cash Equivalent Item [Line Items]        
Restricted cash and restricted cash equivalents: $ 1,408 $ 1,208    
v3.25.4
U.S. and Europe Retrospective Responsibility Plans - Schedule of Changes in the U.S. Litigation Escrow Account (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Escrow Account [Roll Forward]    
Balance as of beginning of period $ 2,990 $ 3,089
Deposits into the U.S. litigation escrow account 500 0
Balance as of end of period 3,300 3,112
Interest Income | Opt-out Merchants    
Escrow Account [Roll Forward]    
Payments to opt-out merchants, net of interest earned on escrow funds $ (190) $ 23
v3.25.4
U.S. and Europe Retrospective Responsibility Plans - Additional Information (Details)
€ in Millions
3 Months Ended
Dec. 31, 2025
EUR (€)
Retrospective Responsibility Plans [Abstract]  
VE covered loss, maximum amount of loss to allow adjustment of conversion rate during six-month period € 20
v3.25.4
U.S. and Europe Retrospective Responsibility Plans - Schedule of Changes in Preferred Stock and Right to Recover Covered Losses (Details)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Sep. 30, 2024
shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance as of beginning of period $ 37,909 [1] $ 39,137    
VE territory covered losses (3) (27)    
Recovery through conversion rate adjustments (1) 0    
Balance as of end of period 38,777 38,296    
As-converted Value of Preferred Stock 1,312   $ 1,389  
Book value of preferred stock 551   745  
Book Value of Preferred Stock, Total 123   232  
Less: right to recover for covered losses (19)   (124)  
As-converted Value of Preferred Stock, Total recovery for covered losses available 1,293   1,265  
Book Value of Preferred of Stock, Total recovery for covered losses available $ 104   $ 108  
Preferred stock, shares outstanding (in shares) | shares 5   5  
Share price (in dollars per share) | $ / shares $ 350.71   $ 341.38  
Preferred Stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance as of beginning of period $ 745 [1] 1,031 [2]    
Recovery through conversion rate adjustments (109) (8)    
Balance as of end of period $ 551 [1] $ 904 [2]    
Preferred stock, shares outstanding (in shares) | shares 5 5 5 5
Right to Recover for Covered Losses        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance as of beginning of period $ (124) [1] $ (104)    
VE territory covered losses (3) (27)    
Recovery through conversion rate adjustments 108 8    
Balance as of end of period (19) (123)    
Series B preferred stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Recovery through conversion rate adjustments 60 5    
As-converted Value of Preferred Stock 518   $ 566  
Book value of preferred stock $ 7   $ 67  
Preferred stock, shares outstanding (in shares) | shares 2   2  
Preferred stock, conversion rate (in percent) 0.5960   0.6690  
Series B preferred stock | Preferred Stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance as of beginning of period $ 67 104    
VE territory covered losses 0 0    
Recovery through conversion rate adjustments (60) (5)    
Balance as of end of period 7 99    
Series C preferred stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Recovery through conversion rate adjustments 49 3    
As-converted Value of Preferred Stock 794   $ 823  
Book value of preferred stock $ 116   $ 165  
Preferred stock, shares outstanding (in shares) | shares 3   3  
Preferred stock, conversion rate (in percent) 0.7170   0.7640  
Series C preferred stock | Preferred Stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance as of beginning of period $ 165 387    
VE territory covered losses 0 0    
Recovery through conversion rate adjustments (49) (3)    
Balance as of end of period $ 116 $ 384    
[1] As of December 31, 2025 and September 30, 2025, the book value of series A convertible participating preferred stock (series A preferred stock) was $428 million and $513 million, respectively. See Note 4—U.S. and Europe Retrospective Responsibility Plans for the book value of series B convertible participating preferred stock (series B preferred stock) and series C convertible participating preferred stock (series C preferred stock).
[2] As of December 31, 2024 and September 30, 2024, the book value of series A preferred stock was $421 million and $540 million, respectively. See Note 4—U.S. and Europe Retrospective Responsibility Plans for the book value of series B and series C preferred stock.
v3.25.4
Fair Value Measurements and Investments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Sep. 30, 2025
Assets    
Investment securities $ 1,697 $ 2,421
Level 1 | Fair Value, Measurements, Recurring    
Assets    
Total 14,242 16,315
Liabilities    
Total 300 268
Level 1 | Fair Value, Measurements, Recurring | Deferred compensation liability    
Liabilities    
Deferred compensation liability 300 268
Level 1 | Fair Value, Measurements, Recurring | Derivative instruments    
Liabilities    
Derivative instruments 0 0
Level 1 | Money market funds | Fair Value, Measurements, Recurring    
Assets    
Cash equivalents and restricted cash equivalents: 12,272 13,760
Other current and non-current assets: 25 28
Level 1 | U.S. Treasury securities | Fair Value, Measurements, Recurring    
Assets    
Investment securities 1,517 2,116
Level 1 | Marketable equity securities | Fair Value, Measurements, Recurring    
Assets    
Marketable equity securities 428 411
Level 1 | U.S. government-sponsored debt securities | Fair Value, Measurements, Recurring    
Assets    
Investment securities 0 0
Level 1 | Derivative instruments | Fair Value, Measurements, Recurring    
Assets    
Other current and non-current assets: 0 0
Level 2 | Fair Value, Measurements, Recurring    
Assets    
Total 263 367
Liabilities    
Total 230 319
Level 2 | Fair Value, Measurements, Recurring | Deferred compensation liability    
Liabilities    
Deferred compensation liability 0 0
Level 2 | Fair Value, Measurements, Recurring | Derivative instruments    
Liabilities    
Derivative instruments 230 319
Level 2 | Money market funds | Fair Value, Measurements, Recurring    
Assets    
Cash equivalents and restricted cash equivalents: 0 0
Other current and non-current assets: 0 0
Level 2 | U.S. Treasury securities | Fair Value, Measurements, Recurring    
Assets    
Investment securities 0 0
Level 2 | Marketable equity securities | Fair Value, Measurements, Recurring    
Assets    
Marketable equity securities 0 0
Level 2 | U.S. government-sponsored debt securities | Fair Value, Measurements, Recurring    
Assets    
Investment securities 180 305
Level 2 | Derivative instruments | Fair Value, Measurements, Recurring    
Assets    
Other current and non-current assets: $ 83 $ 62
v3.25.4
Fair Value Measurements and Investments - Schedule of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Debt Securities (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Sep. 30, 2025
Debt Securities, Available-for-Sale [Line Items]    
Amortized Cost $ 1,683 $ 2,405
Gross Unrealized Gains 14 16
Gross Unrealized Losses 0 0
Fair Value 1,697 2,421
U.S. government-sponsored debt securities    
Debt Securities, Available-for-Sale [Line Items]    
Amortized Cost 179 304
Gross Unrealized Gains 1 1
Gross Unrealized Losses 0 0
Fair Value 180 305
U.S. Treasury securities    
Debt Securities, Available-for-Sale [Line Items]    
Amortized Cost 1,504 2,101
Gross Unrealized Gains 13 15
Gross Unrealized Losses 0 0
Fair Value $ 1,517 $ 2,116
v3.25.4
Fair Value Measurements and Investments - Schedule of Debt Securities Classified by Contractual Maturity Date (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Sep. 30, 2025
Fair Value Disclosures [Abstract]    
Due within one year $ 1,341  
Due after one year through five years 356  
Total $ 1,697 $ 2,421
v3.25.4
Fair Value Measurements and Investments - Additional Information (Details) - USD ($)
Feb. 01, 2025
Dec. 31, 2025
Sep. 30, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Impairment of indefinite-lived intangible assets and goodwill $ 0    
Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Carrying value of debt   $ 21,200,000,000 $ 25,200,000,000
Estimated Fair Value | Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Estimated fair value of debt   $ 19,400,000,000 $ 23,300,000,000
v3.25.4
Fair Value Measurements and Investments - Schedule of Non-Marketable Equity Securities (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Sep. 30, 2025
Fair Value Disclosures [Abstract]      
Initial cost basis $ 714   $ 711
Adjustments:      
Upward adjustments 567   564
Downward adjustments, including impairment (219)   (219)
Carrying amount 1,062   $ 1,056
Upward adjustments 3 $ 0  
Downward adjustments, including impairment $ 0 $ (91)  
v3.25.4
Leases (Details)
$ in Millions
Dec. 31, 2025
USD ($)
Lessee, Lease, Description [Line Items]  
Lessee, operating lease, lease not yet commenced, amount $ 560
Minimum  
Lessee, Lease, Description [Line Items]  
Lessee, operating lease, term of contract (in years) 9 years
Maximum  
Lessee, Lease, Description [Line Items]  
Lessee, operating lease, term of contract (in years) 14 years
v3.25.4
Debt - Schedule of Debt (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Sep. 30, 2025
Debt Instrument [Line Items]    
Unamortized discounts and debt issuance costs $ (158) $ (171)
Hedge accounting fair value adjustments (74) (50)
Total carrying value of debt 21,177 25,171
Current maturities of debt 1,589 5,569
Long-term debt 19,588 19,602
Senior Notes    
Debt Instrument [Line Items]    
Senior notes $ 21,409 25,392
Senior Notes | 3.15% Senior Notes due December 2025 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 3.15%  
Senior notes $ 0 4,000
Effective interest rate (percent) 3.26%  
Senior Notes | 1.90% Senior Notes due April 2027 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 1.90%  
Senior notes $ 1,500 1,500
Effective interest rate (percent) 2.02%  
Senior Notes | 0.75% Senior Notes due August 2027 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 0.75%  
Senior notes $ 500 500
Effective interest rate (percent) 0.84%  
Senior Notes | 2.75% Senior Notes due September 2027 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.75%  
Senior notes $ 750 750
Effective interest rate (percent) 2.91%  
Senior Notes | 2.05% Senior Notes due April 2030 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.05%  
Senior notes $ 1,500 1,500
Effective interest rate (percent) 2.13%  
Senior Notes | 1.10% Senior Notes due February 2031 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 1.10%  
Senior notes $ 1,000 1,000
Effective interest rate (percent) 1.20%  
Senior Notes | 4.15% Senior Notes due December 2035 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 4.15%  
Senior notes $ 1,500 1,500
Effective interest rate (percent) 4.23%  
Senior Notes | 2.70% Senior Notes due April 2040 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.70%  
Senior notes $ 1,000 1,000
Effective interest rate (percent) 2.80%  
Senior Notes | 4.30% Senior Notes due December 2045 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 4.30%  
Senior notes $ 3,500 3,500
Effective interest rate (percent) 4.37%  
Senior Notes | 3.65% Senior Notes due September 2047 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 3.65%  
Senior notes $ 750 750
Effective interest rate (percent) 3.73%  
Senior Notes | 2.00% Senior Notes due August 2050 | U.S.    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.00%  
Senior notes $ 1,750 1,750
Effective interest rate (percent) 2.09%  
Senior Notes | 1.50% Senior Notes due June 2026 | Europe    
Debt Instrument [Line Items]    
Stated interest rate (percent) 1.50%  
Senior notes $ 1,591 1,587
Effective interest rate (percent) 1.71%  
Senior Notes | 2.25% Senior Notes due May 2028 | Europe    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.25%  
Senior notes $ 1,473 1,470
Effective interest rate (percent) 2.57%  
Senior Notes | 2.00% Senior Notes due June 2029 | Europe    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.00%  
Senior notes $ 1,178 1,176
Effective interest rate (percent) 2.13%  
Senior Notes | 3.125% Senior Notes due May 2033 | Europe    
Debt Instrument [Line Items]    
Stated interest rate (percent) 3.125%  
Senior notes $ 1,178 1,176
Effective interest rate (percent) 3.20%  
Senior Notes | 2.375% Senior Notes due June 2034 | Europe    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.375%  
Senior notes $ 766 764
Effective interest rate (percent) 2.53%  
Senior Notes | 3.50% Senior Notes due May 2037 | Europe    
Debt Instrument [Line Items]    
Stated interest rate (percent) 3.50%  
Senior notes $ 766 764
Effective interest rate (percent) 3.62%  
Senior Notes | 3.875% Senior Notes due May 2044 | Europe    
Debt Instrument [Line Items]    
Stated interest rate (percent) 3.875%  
Senior notes $ 707 $ 705
Effective interest rate (percent) 4.02%  
v3.25.4
Debt - Additional Information (Details)
$ in Billions
3 Months Ended
Dec. 31, 2025
USD ($)
December 2025 Notes | Senior Notes  
Debt Instrument [Line Items]  
Repayments of senior debt $ 4.0
v3.25.4
Settlement Guarantee Management (Details) - USD ($)
$ in Billions
3 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Settlement Guarantee Management [Abstract]    
Maximum settlement exposure $ 168.6  
Average daily settlement exposure 98.4  
Total collateral $ 8.8 $ 8.8
v3.25.4
Segment Information (Details)
3 Months Ended
Dec. 31, 2025
segment
Segment Reporting [Abstract]  
Number of Reportable Segments 1
v3.25.4
Stockholders' Equity - Schedule of Stock by Class (Details)
shares in Millions
Dec. 31, 2025
shares
Sep. 30, 2025
shares
Schedule of Common Stock as Converted [Line Items]    
Preferred stock, shares outstanding (in shares) 5 5
As-converted Class A Common Stock (in shares) 1,918 1,930
Series A preferred stock    
Schedule of Common Stock as Converted [Line Items]    
Preferred stock, shares outstanding (in shares) 0 0
Preferred stock, conversion rate into Class A Common Stock 100.0000 100.0000
As-converted Class A Common Stock (in shares) 7 8
Series B preferred stock    
Schedule of Common Stock as Converted [Line Items]    
Preferred stock, shares outstanding (in shares) 2 2
Preferred stock, conversion rate into Class A Common Stock 0.5960 0.6690
As-converted Class A Common Stock (in shares) 1 2
Series C preferred stock    
Schedule of Common Stock as Converted [Line Items]    
Preferred stock, shares outstanding (in shares) 3 3
Preferred stock, conversion rate into Class A Common Stock 0.7170 0.7640
As-converted Class A Common Stock (in shares) 2 2
Class A common stock    
Schedule of Common Stock as Converted [Line Items]    
Common stock, shares outstanding (in shares) 1,683 1,691
Common stock, conversion rate into Class A Common Stock 0 0
As-converted Class A Common Stock (in shares) 1,683 1,691
Class B-1 common stock    
Schedule of Common Stock as Converted [Line Items]    
Common stock, shares outstanding (in shares) 5 5
Common stock, conversion rate into Class A Common Stock 1.5491 1.5549
As-converted Class A Common Stock (in shares) 7 8
Class B-2 common stock    
Schedule of Common Stock as Converted [Line Items]    
Common stock, shares outstanding (in shares) 120 120
Common stock, conversion rate into Class A Common Stock 1.5108 1.5223
As-converted Class A Common Stock (in shares) 182 183
Class C common stock    
Schedule of Common Stock as Converted [Line Items]    
Common stock, shares outstanding (in shares) 9 9
Common stock, conversion rate into Class A Common Stock 4.0000 4.0000
As-converted Class A Common Stock (in shares) 36 36
v3.25.4
Stockholders' Equity - Schedule of Effect of VE Territory Covered Losses Recovery on the Company Repurchasing its Common Stock (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Conversion of Stock [Line Items]    
Reduction in equivalent number of class A common stock (in shares) 1 0
Effective price per share (in dollars per share) $ 354.46 $ 0
Deposits into the U.S. litigation escrow account $ 500 $ 0
Recovery through conversion rate adjustments $ (1) $ 0
Series B preferred stock    
Conversion of Stock [Line Items]    
Reduction in equivalent number of class A common stock (in shares) 0 0
Effective price per share (in dollars per share) $ 330.96 $ 312.39
Recovery through conversion rate adjustments $ 60 $ 5
Series C preferred stock    
Conversion of Stock [Line Items]    
Reduction in equivalent number of class A common stock (in shares) 0 0
Effective price per share (in dollars per share) $ 330.96 $ 312.39
Recovery through conversion rate adjustments $ 49 $ 3
v3.25.4
Stockholders' Equity - Share Repurchases in the Open Market (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Sep. 30, 2025
Equity, Class of Treasury Stock [Line Items]      
Total cost $ 3,765 $ 3,940  
Unsettled repurchases $ 5,576   $ 5,466
Class A common stock      
Equity, Class of Treasury Stock [Line Items]      
Shares repurchased in the open market (in shares) 11 13  
Average repurchase cost per share (in dollars per share) $ 342.13 $ 300.61  
Total cost $ 3,765 $ 3,940  
Unsettled repurchases $ 40 $ 70  
v3.25.4
Stockholders' Equity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Billions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Jan. 27, 2026
Apr. 30, 2025
Equity, Class of Treasury Stock [Line Items]        
Share repurchase program       $ 30.0
Share repurchase programs authorized $ 21.1      
Dividends paid $ 1.3 $ 1.2    
Subsequent Event        
Equity, Class of Treasury Stock [Line Items]        
Quarterly cash dividend (in dollars per share)     $ 0.67  
v3.25.4
Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]    
Income Allocation - Basic $ 5,853 $ 5,119
Class A common stock    
Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]    
Income Allocation - Basic $ 5,117 $ 4,466
Weighted- Average Shares Outstanding - Basic (in shares) 1,687 1,729
Earnings per Share - Basic (in dollars per share) $ 3.03 $ 2.58
Income Allocation - Diluted $ 5,853 $ 5,119
Weighted- Average Shares Outstanding - Diluted (in shares) 1,933 1,985
Earnings per Share - Diluted (in dollars per share) $ 3.03 $ 2.58
Class B-1 common stock    
Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]    
Income Allocation - Basic $ 23 $ 20
Weighted- Average Shares Outstanding - Basic (in shares) 5 5
Earnings per Share - Basic (in dollars per share) $ 4.71 $ 4.04
Income Allocation - Diluted $ 23 $ 20
Weighted- Average Shares Outstanding - Diluted (in shares) 5 5
Earnings per Share - Diluted (in dollars per share) $ 4.71 $ 4.04
Class B-2 common stock    
Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]    
Income Allocation - Basic $ 555 $ 480
Weighted- Average Shares Outstanding - Basic (in shares) 120 120
Earnings per Share - Basic (in dollars per share) $ 4.61 $ 3.99
Income Allocation - Diluted $ 554 $ 479
Weighted- Average Shares Outstanding - Diluted (in shares) 120 120
Earnings per Share - Diluted (in dollars per share) $ 4.61 $ 3.98
Class C common stock    
Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]    
Income Allocation - Basic $ 108 $ 98
Weighted- Average Shares Outstanding - Basic (in shares) 9 10
Earnings per Share - Basic (in dollars per share) $ 12.13 $ 10.33
Income Allocation - Diluted $ 108 $ 98
Weighted- Average Shares Outstanding - Diluted (in shares) 9 10
Earnings per Share - Diluted (in dollars per share) $ 12.11 $ 10.32
Participating securities    
Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]    
Income Allocation - Basic $ 50 $ 55
Income Allocation - Diluted $ 50 $ 55
v3.25.4
Earnings Per Share - Schedule of Weighted Average Number of Shares (Details) - shares
shares in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Class B-1 common stock    
Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]    
Weighted-average as-converted common stock used in income allocation (in shares) 8 8
Class B-2 common stock    
Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]    
Weighted-average as-converted common stock used in income allocation (in shares) 183 186
Class C common stock    
Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]    
Weighted-average as-converted common stock used in income allocation (in shares) 36 38
Participating securities    
Schedule of Earnings Per Share, Basic and Diluted, by Common Class, Including Two Class Method [Line Items]    
Weighted-average as-converted common stock used in income allocation (in shares) 17 21
v3.25.4
Share-based Compensation - Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details)
3 Months Ended
Dec. 31, 2025
$ / shares
shares
Non-qualified stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Granted (in shares) | shares 714,321
Weighted-Average Grant Date Fair Value (in dollars per share) $ 76.23
Weighted-Average Exercise Price (in dollars per share) $ 324.13
Restricted stock units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Granted (in shares) | shares 2,458,039
Weighted-Average Grant Date Fair Value (in dollars per share) $ 324.82
Performance-based shares  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Granted (in shares) | shares 381,324
Weighted-Average Grant Date Fair Value (in dollars per share) $ 344.15
v3.25.4
Share-based Compensation - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
2007 Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Share-based compensation expense $ 221 $ 215
v3.25.4
Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Effective income tax rate reconciliation, percent (in percent) 13.00% 17.00%
Net tax benefit $ 333  
Unrecognized tax benefits, period increase, gross 13  
Unrecognized tax benefits, period increase (decrease), net $ 11  
v3.25.4
Legal Matters - Schedule of Accrued Litigation for Both Covered and Non-Covered Litigation (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Loss Contingency Accrual [Roll Forward]    
Balance at beginning of period $ 3,033 $ 1,727
Balance at end of period 3,406 1,649
Uncovered Litigation    
Loss Contingency Accrual [Roll Forward]    
Provision for legal matters 1 17
Covered Litigation    
Loss Contingency Accrual [Roll Forward]    
Provision for legal matters 707 34
Payments for legal matters (335) (129)
U.S. Covered Litigation    
Loss Contingency Accrual [Roll Forward]    
Balance at beginning of period 2,698 1,537
Provision for legal matters 707 27
Payments for legal matters (207) 0
Balance at end of period 3,198 1,564
VE Territory Covered Litigation    
Loss Contingency Accrual [Roll Forward]    
Balance at beginning of period 9 72
Provision for legal matters 0 7
Payments for legal matters (4) (21)
Balance at end of period $ 5 $ 58
v3.25.4
Legal Matters - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Loss Contingencies [Line Items]    
Deposits into the U.S. litigation escrow account $ 500 $ 0
Interchange Multidistrict Litigation    
Loss Contingencies [Line Items]    
Settlement percentage (in percent) 87.00%  
U.S. Covered Litigation    
Loss Contingencies [Line Items]    
Provision for legal matters $ 707 $ 27